Esther Choo, M.D., speaks about various COVID-related topics, including vaccine waivers, vaccination rates and the origin of the virus: "I want to be really clear that much of the speculation around laboratory origins has been just that, speculation, not credible evidence, just a lot of fear and hypothesizing."
In a story noting that May is Skin Cancer Awareness Month, Sancy Leachman, M.D., Ph.D., says: “I can’t tell you how many young women I’ve had come in with melanoma or more than one melanoma who have been victims of the suntan salon trend.”
Story cites OHSU’s community mass vaccination site at the Portland airport in a story about relatively low rates of vaccinations in lower-income neighborhoods of color in Multnomah County.
OHSU’s Serial Measurements of Molecular and Architectural Responses to Therapy, or SMMART, program is expanding its multiomics precision cancer management approach to more types of cancer; Gordon Mills, M.D., Ph.D., says: “If you're going to understand what is truly happening, you need to be able to capture what is going on in the tumor pre-therapy, with a deep analysis of DNA, RNA, and protein, and then following therapy.”
In a story about pandemic-related alcohol consumption, Jessica Gregg, M.D., describes the “gray area” of borderline unhealthy drinking habits: “Someone’s not so far into their drinking that their body is dependent … they’re not in the severe end of the spectrum but they are drinking in a way that makes their life worse as opposed to better.”
Kenton Gregory, M.D., and OHSU are collaborating with Philips North America to develop artificial intelligence applications to boost health care capacity during mass casualty events.
OHSU experts Dawn Nolt, M.D., and Monique Bohun, M.D., help quell concern regarding reports of myocarditis following COVID-19 mRNA vaccine: “Reported cases are extremely rare.”